Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...

Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ETCompany ParticipantsEli Kammerman - VP of Business ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

The global capnography equipment market is on the brink of significant expansion, with projections indicating a robust Compound Annual Growth Rate (CAGR) of 4.4% over the forecast period. Anticipated ...

A Delaware jury has found health tech company Masimo guilty of infringing Apple’s Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold, and ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...

A jury in Delaware awarded Apple $250 in a lawsuit against Masimo Corp., finding that some of the company’s older smartwatches infringed on Apple Watch design patents. The verdict is the latest ...

Apple wins a symbolic $250 in damages as a federal jury finds that Masimo's smartwatch designs and charger infringe on Apple Watch patents. Despite the minimal monetary award, Apple claims the ...

Apple said in a statement that it was "glad the jury's decision today will protect the innovations we advance on behalf of our customers." ...

A federal jury ruled in favor of Apple in a patent infringement case against Masimo, determining that an older version of Masimo's smartwatches violated Apple's design patents. Despite the win ...